Market Research Report

Global Arterial Cannula Market Research Report: Forecast (2023-2028)

By Product (Cardiac Cannulas, Nasal Cannulas, Vascular Cannulas, Dermatology Cannulas, Arthroscopy Cannulas, Arthroscopy Cannulas), By Type (Neonatal Cannulas, Straight Cannulas, W...inged Cannula, Wing with Port Cannula, Others), By Size (14G, 16G, 18G, 20G, 22G, 24G, 26G), By Material (Plastic [PVC] Cannulas, Silicone Cannulas, Metal Cannulas [Stainless Steel]), By Application (Cardiovascular Surgery, Oxygen Therapy, General Surgery, Cosmetic/Plastic Surgery, Orthopedic Surgery, Others), By End User (Hospitals, Ambulatory Surgery Centers [ASCs], Others), By Region (North America, South America, Europe, The Middle East & Africa, Asia-Pacific), By Company (Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences , LivaNova Plc, Medtronic Plc , Smith & Nephew PLC, Smiths Medical Inc., Teleflex Incorporated, Terumo Corporation, others) Read more

  • Healthcare
  • Apr 2023
  • 174
  • HC22133

Market Definition

An Arterial Cannula is a flexible plastic tube designed to deliver blood to the patient during cardiopulmonary bypass. The procedure involved is called Arterial cannulation, which is frequently performed in acute and critical care settings. It is an invasive means to measure blood and mean arterial pressure more accurately than non-invasive means.

Market Insights & Analysis: Global Arterial Cannula Market (2023-28)

The Global Arterial Cannula Market is projected to grow at a CAGR of around 6.5% during the forecast period, i.e., 2023-28. The worldwide prevalence of heart disorders has increased over the years due to various factors such as consuming unhealthy diets, sedentary lifestyles, increasing smoking habits, physical inactivity, or family history of chronic disorders such as hypertension, diabetes, or hyperlipidemia to contribute to the rising incidence of cardiovascular diseases. Thus, the growing prevalence of cardiovascular and cardiopulmonary illnesses that require cardiopulmonary pass surgery CABG, dialysis, and Extracorporeal Membrane Oxygenation ECMO aids the demand for arterial cannula.

Recent studies have shown that more than half of patients in the intensive care unit with kidney injury may require dialysis, while over one-third of patients hospitalized with COVID-19 may develop kidney injury, indicating a potential rise in health issues related to the heart and kidneys. Thus, there is a growing preference for minimally invasive techniques as it facilitates less pain, quicker recovery, further fueling the demand for arterial cannulas for surgical procedures.

Report Coverage Details
Study Period Historical Data: 2018-21
Base Year: 2022
Forecast Period: 2023-28
CAGR (2023-2028) 6.5%
Regions Covered North America: US, Canada, Mexico
Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
South America: Brazil, Argentina, Rest of South America
Middle East & Africa: UAE, Saudi Arabia, Qatar, Egypt, South Africa, Rest of the Middle East & Africa
Key Companies Profiled Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences , LivaNova Plc, Medtronic Plc , Smith & Nephew PLC, Smiths Medical Inc., Teleflex Incorporated, Terumo Corporation, others
Unit Denominations USD Million/Billion

 

According to the fact sheet updated by the American Heart Association in 2022, North Africa & the Middle East, Central, & South Asia, and Eastern Europe had the highest prevalence rates of ischemic heart disease (IHD) in the world in 2020. Citing the high level of mortality due to IHD, the respective government across the regions seeks to improve healthcare infrastructure through numerous initiatives in order to strengthen medical care and minimize the cases, broadening the industry's potential.

Market Dynamics

Key Driver: Prevalence of Cardiovascular and Cardiopulmonary Illnesses Resulting in Immediate Need for By-Pass Surgeries

According to the study, The Global Burden of Cardiovascular Diseases and Risk, published by JACC, Journal of the American College of Cardiology in December 2022, Cardiovascular diseases (CVDs) have collectively remained the leading causes of death globally, substantially contributing to the loss of health and additional costs on the health system. The more frequent instances of kidney dysfunction, dietary risks, tobacco smoking, secondhand tobacco smoke, high systolic blood pressure, high LDL-C, high body mass index (BMI), high fasting plasma glucose, high alcohol use, and low physical activity as the possible risk factors are anticipated to raise the chances of such diseases.

Given the criticality of such conditions and the immediate urge to minimize them, invasive and efficacious surgical techniques are surfacing, giving rise to innovative medical devices, including arterial cannulae, by numerous manufacturers. For instance,

  • Medtronic plc, an American medical device company, has come up with product variations to facilitate a variety of surgical techniques and to accommodate varying patient anatomies. In fact, citing the need for distinct devices for pediatrics and adults, the company offers arterial cannulae sizes from 6 Fr to 24 Fr in various tip configurations, lengths, and connector sizes.

Thus, rising cardiovascular conditions and pulmonary illnesses has increased the number of bypass surgeries and other similar procedures, particularly among the geriatric population, significantly elevating the demand for cannulae market.


Global Arterial Cannula Market Research Report: Forecast (2023-2028)

Possible Restraint: Limited Decentralization of Cardiac Surgical Procedures

The Arterial Cannula Market faces the challenge of limited decentralization of cardiac surgical procedures, which are unlikely to be available beyond capital cities in the short term, thereby negatively influencing its demand. However, governments across the world, specially developing countries can invest in outreach clinics for specialist physicians and surgeons to bridge this gap. In addition, there is a need for a comprehensive, multidisciplinary approach to include palliative care and rehabilitation for patients in remote areas who are currently underserved.

Growth Opportunity: Scaling Up of Cardiac Surgical Capacity Across the African Continent

The urgent need to address the lack of access to cardiac surgery in African countries presents a significant opportunity for manufacturers of the arterial cannula market. While degenerative cardiovascular diseases are on the rise, structural conditions such as congenital heart disease (CHD) and rheumatic heart disease (RHD) still account for a higher morbidity and mortality rate in Africa than in the rest of the world. As African leaders endorse resolutions to end RHD and scale-up cardiac surgical capacity, the demand for surgical equipment and supplies such as arterial cannulas is expected to increase. Governments in countries such as Namibia, Zambia, and Uganda have already taken steps to improve access to tertiary care, but more needs to be done to meet the current demand for cardiac surgical services in Africa.

Key Trend: Growing Adoption of Arterial Cannulation in ICU and Critical Care Setting

Arterial cannulation has become vital for monitoring and stabilizing critically ill patients, drastically increasing after the covid-19 pandemic. It has become standard practice in critical care areas for certain patient populations that are at risk of rapid decline if changes in hemodynamic status are not detected. As healthcare professionals become more comfortable with arterial cannulation and monitoring, it is expected to improve patient outcomes and aid in medical decision-making in critical healthcare settings. Backed by these aspects, the adoption of the arterial cannula has gained traction in recent years.

Market Segmentation

Based on Application

  • Cardiovascular Surgery
  • Oxygen Therapy
  • General Surgery
  • Cosmetic/Plastic Surgery
  • Orthopedic Surgery
  • Others

Among all, the Cardiovascular Surgical applications of the cannula are anticipated to register the most remarkable growth in the forecast years owing to the high prevalence of cardiac issues globally.

The advancement of cardiac surgery and the increased use of cardiopulmonary bypass have positively influenced the adoption of arterial cannula in cardiovascular applications. Besides, a rising need to choose the right cannulation site and appropriate cannulas to ensure successful outcomes has been demonstrated by numerous surgeons.

It has led to an increased demand for innovative arterial cannula products that cater to various surgical procedures, swiftly augmenting the market growth. As a result, the arterial cannula market has experienced significant growth as manufacturers continue to invest in research and development to improve the quality and effectiveness of their products.

Based on the End User

  • Hospitals
  • Ambulatory Surgery Centers (ASCs)
  • Others

Among the three, Hospitals dominated the industry with the highest market share during the historical period and are expected to prevail in the same trend by garnering the largest market share in the forecast period. It is aided by the exponential number of surgeries being performed in hospital settings. Besides, the increasing number of development in the healthcare sector in numerous developing and developed countries to expand and secure the health of the populace is likely to bode well for the market. Moreover, ever-increasing admissions in hospitals due to the rising number of chronic disorders and health issues are likely to bode well for the market revenue.

Contrarily, Ambulatory Surgery Centers (ASCs) are also projected to experience considerable industrial expansion in the forthcoming years, accredited by the increasing preference towards ASCs to benefit from reduced cost and stay. Furthermore, favorable government initiatives to strengthen the quality of ASCs are adding to the market value.

Regional Projection

Geographically, the Global Arterial Cannula Market expands across:

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific

Globally, North America is anticipated to garner the highest market share in the forecasting. The market growth is accredited to the rising cardiac surgeries and the high prevalence of chronic kidney diseases in the region. Moreover, the presence of developed and highly advanced healthcare further adds to the market value. Additionally, the industry is also driven by the presence of big pharma companies and major market players. Numerous research and development in the medical industry coupled with the heavy investment by the government and the market participants are likely to bode well for the industry.

Recent Developments in the Global Arterial Cannula Market

  • In April 2023, Boston Scientific Corporation announced its intention to acquire Shockwave Medical, a company specializing in interventional cardiovascular procedures. This acquisition is part of Boston Scientific's strategy to expand its range of cardiovascular devices, as Shockwave Medical is a leading medical device manufacturer, based in California.

Do you require further assistance?

1. The sample report seeks to acquaint you with the layout and the overall research content.

2. The deliberate utilization of the report may further streamline operations while maximizing your revenue.

3. To gain an unmatched competitive advantage in your industry, you can customize the report by adding more segments and specific countries suiting your needs.

4. For a better understanding of the contemporary market scenario, feel free to connect to our knowledgeable analysts.

Frequently Asked Questions

   A. The Global Arterial Cannula Market is projected to grow at a CAGR of around 6.5% during 2023-28.

   A. Prevalence of cardiovascular and cardiopulmonary illnesses resulting in immediate need for by-pass surgeries is expected to drive the market during 2023-28.

   A. Boston Scientific Corporation, CONMED Corporation, Edwards Lifesciences, Medtronic Plc, Smith & Nephew PLC, Smiths Medical Inc., LivaNova Plc, Teleflex Incorporated, Terumo Corporation, and others aree the top players in the Global Arterial Cannula Market.

   A. Cardiovascular Surgery is anticipated to emerge as an area of remunerative opportunities for the leading players in the Global Arterial Cannula Market during the forecast period.

   A. Globally, North America would provide lucrative prospects for the Global Arterial Cannula Market in the years ahead.

   A. Growing adoption of arterial cannulation in ICU and critical care setting are the key trend shaping the Global Arterial Cannula Market.

   A. Scaling up of cardiac surgical capacity across the African continent is likely to raise lucrative opportunities driving the Global Arterial Cannula Market through 2028

   A. Limited decentralization of cardiac surgical procedures is the possible restraint affecting the growth of the Global Arterial Cannula Market during 2023-2028.

  1. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  2. Market Segmentation
  3. Executive Summary
  4. Global Arterial Cannula Market Regulations, Norms, & Product Standards
  5. Global Arterial Cannula Market Trends & Developments
  6. Global Arterial Cannula Market Dynamics
    1. Drivers
    2. Challenges
  7. Global Arterial Cannula Market Imports, Exports Statistics
  8. Global Arterial Cannula Market Hotspots & Opportunities
  9. Global Arterial Cannula Market Value Chain & Stakeholder Margin Analysis
  10. Global Arterial Cannula Market Analysis (2018-2028F)
    1. Market Size & Analysis
      1. Market Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product
        1. Cardiac Cannulas
        2. Nasal Cannulas
        3. Vascular Cannulas
        4. Dermatology Cannulas
        5. Arthroscopy Cannulas
        6. Arthroscopy Cannulas
      2. By Type
        1. Neonatal Cannulas
        2. Straight Cannulas
        3. Winged Cannula
        4. Wing with Port Cannula
        5. Others
      3. By Size
        1. 14G
        2. 16G
        3. 18G
        4. 20G
        5. 22G
        6. 24G
        7. 26G
      4. By Material
        1. Plastic (PVC) Cannulas
        2. Silicone Cannulas
        3. Metal Cannulas (Stainless Steel)
      5. By Application
        1. Cardiovascular Surgery
        2. Oxygen Therapy
        3. General Surgery
        4. Cosmetic/Plastic Surgery    
        5. Orthopedic Surgery
        6. Others
      6. By End User
        1. Hospitals
        2. Ambulatory Surgery Centers (ASCs)
        3. Others
      7. By company
        1. Revenue Shares
        2. Competition Characteristics
      8. By Region
        1. North America
        2. South America
        3. Europe
        4. The Middle East & Africa
        5. Asia-Pacific
  11. North America Arterial Cannula Market Analysis (2018-2028F)
    1. Market Size & Analysis
      1. Market Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product
      2. By Type
      3. By Size
      4. By Material
      5. By Application
      6. By End User
      7. BY company
      8. By Country
        1. The US
        2. Canada
        3. Mexico
    3. The US Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
    4. Canada Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
    5. Mexico Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
  12. South America Arterial Cannula Market Analysis (2018-2028F)
    1. Market Size & Analysis
      1. Market Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product
      2. By Type
      3. By Size
      4. By Material
      5. By Application
      6. By End User
      7. BY company
      8. By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    3. Brazil Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
    4. Argentina Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
  13. Europe Arterial Cannula Market Analysis (2018-2028F)
    1. Market Size & Analysis
      1. Market Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product
      2. By Type
      3. By Size
      4. By Material
      5. By Application
      6. By End User
      7. BY company
      8. By Country
        1. Germany
        2. The UK
        3. France
        4. Spain
        5. Italy
        6. Rest of Europe
    3. Germany Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
    4. France Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
    5. The UK Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
    6. Spain Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
    7. Italy Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
  14. The Middle East & Africa Arterial Cannula Market Analysis (2018-2028F)
    1. Market Size & Analysis
      1. Market Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product
      2. By Type
      3. By Size
      4. By Material
      5. By Application
      6. By End User
      7. BY company
      8. By Country
        1. The UAE
        2. Saudi Arabia
        3. Qatar
        4. Egypt
        5. South Africa
        6. Rest of the Middle East & Africa
    3. The UAE Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
    4. Saudi Arabia Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
    5. Qatar Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
    6. Egypt Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
    7. South Africa Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
  15. Asia-Pacific Arterial Cannula Market Analysis (2018-2028F)
    1. Market Size & Analysis
      1. Market Revenues (USD Million)
    2. Market Share & Analysis
      1. By Product
      2. By Type
      3. By Size
      4. By Material
      5. By Application
      6. By End User
      7. BY company
      8. By Country
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia
        6. Rest of Asia-Pacific
    3. China Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
    4. India Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
    5. Japan Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
    6. South Korea Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
    7. Australia Arterial Cannula Market Analysis (2018-2028F)
      1. By Type
      2. By End User
  16. Competitive Benchmarking & Company Profiles
    1. Competition Matrix
      1. Product Portfolio
      2. Target Markets
      3. Target End Users
      4. Research & Development
      5. Strategic Alliances
      6. Strategic Initiatives
    2. Company Profiles (Business Description, Product Offering, Strategic Alliances or Partnerships, etc)
      1. Boston Scientific Corporation
      2. CONMED Corporation
      3. Edwards Lifesciences 
      4. LivaNova Plc
      5. Medtronic Plc 
      6. Smith & Nephew PLC
      7. Smiths Medical Inc.
      8. Teleflex Incorporated
      9. Terumo Corporation
      10. others
  17. Copyright & Disclaimer


Arterial Cannula Market - Segmentation Slide